TORL BioTherapeutics’ $158 Million Series B-2 Financing

Schulte Roth & Zabel represented Deep Track Capital, while Crandon Law represented TORL BioTherapeutics in the transaction.TORL BioTherapeutics announced its closing of an oversubscribed $158 million Series B-2…

This content is for Standard 1 Year members only.
Login Join Now

Cooper Equipment Rentals’ Acquisition of Action Equipment Rentals

Fulcrum Therapeutics’ Collaboration and License Agreement with Sanofi

Gilgamesh Pharmaceuticals’ Collaboration with AbbVie

Cresud’s US$10 Million Notes Offering

Raghsa’s US$10 Million Notes Issuance

San Miguel’s Public Offering

L’Occitane International SA’s €6 Billion Privatization

Abound’s Additional £800 Million Funding Round

Kindred Nurseries’ Acquisition Of Whitton Day Nursery

JS Virginia Proprietary Ltd’s Financing Of Renewable Project In South Africa

Injaro Investment Advisors’ Equity Investment in NME

Dislog Group’s Acquisition of CMB Plastique Maroc

OSN’s Acquisition of a Control Stake in Anghami

McLaren’s Successful Reorganisation with Mumtalakat

Skyports Infrastructure’s Dubai Launch

Marketingforce Management’s IPO on the Hong Kong Stock Exchange

Salmon’s $25 Million Series A-1 Financing

Hyundai Card’s $500 Million Notes Issuance

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

BCLP Makes New Leadership Appointments

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

Intellectual Property Partner Jeff Morton Joins Haynes Boone in Southern California

TORL BioTherapeutics’ $158 Million Series B-2 Financing

Author: Laura Testa